(Q1998021)

Statements

instance of

type of chemical entity

0 references

subclass of

protein

0 references

has use

medication

1 reference

stated in

DrugBank

DrugBank ID

06366

language of work or name

English

title

Pertuzumab (English)

publication date

17 November 2015

facet of

breast cancer

0 references

image of molecular model or crystal lattice model

Pertuzumab-HER2 complex 1S78.png
490 × 435; 89 KB

depicts

ribbon diagram

0 references

active ingredient in

Perjeta

1 reference

European Medicines Agency product number

EMEA/H/C/002547

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002547/human_med_001628.jsp

retrieved

22 March 2017

World Health Organisation international non-proprietary name

pertuzumab (English)

1 reference

stated in

ChEMBL

ChEMBL ID

CHEMBL2007641

language of work or name

English

title

Pertuzumab (English)

retrieved

19 January 2016

physically interacts with

Erb-b2 receptor tyrosine kinase 2

subject has role

reaction inhibitor

1 reference

stated in

Open Targets Platform

retrieved

14 August 2023

reference URL

https://platform.opentargets.org/drug/CHEMBL2007641

legal status (medicine)

boxed warning

1 reference

reference URL

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

title

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

US pregnancy category D

1 reference

imported from Wikimedia project

English Wikipedia

has characteristic

biopharmaceutical

1 reference

stated in

DrugBank

DrugBank ID

06366

language of work or name

English

title

Pertuzumab (English)

publication date

17 November 2015

subject has role

antineoplastic

1 reference

stated in

Medical Subject Headings

MeSH descriptor ID

C485206

retrieved

15 March 2018

immunological antineoplastic agent

1 reference

stated in

Medical Subject Headings

MeSH descriptor ID

C485206

retrieved

15 March 2018

monoclonal antibody

1 reference

stated in

DrugBank

DrugBank ID

06366

language of work or name

English

title

Pertuzumab (English)

publication date

17 November 2015

developmental toxicant

start time

27 January 2017

1 reference

stated in

California Proposition 65 list of chemicals

retrieved

18 March 2020

reference URL

https://oehha.ca.gov/chemicals/pertuzumab

Identifiers